DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 156 filers reported holding DIPLOMAT PHARMACY INC in Q4 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $7,436,000 | -31.1% | 552,426 | -0.7% | 0.10% | -25.8% |
| Q3 2018 | $10,793,000 | +1951.9% | 556,051 | +2600.6% | 0.13% | +1728.6% |
| Q2 2018 | $526,000 | -36.9% | 20,590 | -50.3% | 0.01% | +16.7% |
| Q1 2018 | $834,000 | +99.5% | 41,400 | +98.9% | 0.01% | +20.0% |
| Q4 2017 | $418,000 | -3.5% | 20,815 | -0.4% | 0.01% | -16.7% |
| Q3 2017 | $433,000 | +129.1% | 20,895 | +64.3% | 0.01% | +100.0% |
| Q2 2017 | $189,000 | -6.9% | 12,720 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $203,000 | +43.0% | 12,720 | +12.9% | 0.00% | +50.0% |
| Q4 2016 | $142,000 | -61.7% | 11,270 | -15.1% | 0.00% | -66.7% |
| Q3 2016 | $371,000 | -20.0% | 13,270 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $464,000 | +27.5% | 13,270 | -0.2% | 0.01% | +16.7% |
| Q1 2016 | $364,000 | -19.3% | 13,290 | +0.8% | 0.01% | -25.0% |
| Q4 2015 | $451,000 | – | 13,185 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |